SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Marie Curie — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMarie Curie
Date of birth1867-11-07
IdentifiersMRN HR-ET013-SYN-TD; SSN (made up) 000-13-2758
Document date1934-05-18
AuthorAdaeze Nwosu, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Hematology consultation for pancytopenia, with bone marrow aspirate and biopsy. [S]

History of Present Illness

Madame Curie is seen in hematology one week after her primary care visit, where two months of fatigue, breathlessness on stairs, easy bruising, and a recent fever led to a blood count showing pancytopenia with a low reticulocyte count. She received two units of irradiated red cells that day. She is less breathless since the transfusion but still tires by midafternoon. New bruises appear on her arms and shins without injury; she has had no nosebleeds, gum bleeding, blood in the urine or stool, or further fever. She has worked for decades with radium sources and X-ray equipment, much of it before modern shielding, and she has stopped laboratory work since the last visit. She wants the data and the plan in detail. [S]

ElementDetail
Since the transfusionLess breathless; fatigue by midafternoon
BleedingBruises on arms and shins without injury; no mucosal, urinary, or bowel bleeding
InfectionNo fever since the first visit
ExposureDecades of occupational ionizing radiation; no further exposure since the first visit
Patient preferenceWants the full data and plan

Review of Systems

SystemResultFinding
ConstitutionalPositiveFatigue by midafternoon; no fever, night sweats, or weight loss
HematologicPositiveEasy bruising; no mucosal bleeding
CardiovascularPositiveBreathless on stairs, better since transfusion; no chest pain
EyesPositiveGlare and blurred reading vision in the right eye
SkinPositiveThin, scarred fingertips; no rash

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Cyclosporine (modified) 100 mg oral capsule, one capsule twice daily, dose adjusted to trough levels by hematologyOne capsule by mouth twice daily; hematology adjusts the dose to trough levelsOral route1934-05-18activeS
Eltrombopag 75 mg oral tablet, two tablets (150 mg) once daily on an empty stomachTwo tablets by mouth once daily, two hours before or four hours after food, dairy, or antacidsOral route1934-05-18activeS
Acyclovir 400 mg oral tablet, one tablet twice daily during immunosuppressionOne tablet by mouth twice dailyOral route1934-05-18activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1934-05-18Body height157cmS
1934-05-18Body weight51kgS
1934-05-18Body mass index (BMI) [Ratio]20.7kg/m2S
1934-05-18Systolic blood pressure116mm[Hg]S
1934-05-18Diastolic blood pressure70mm[Hg]S
1934-05-18Heart rate92/minS
1934-05-18Respiratory rate16/minS
1934-05-18Body temperature36.9CelS
1934-05-18Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1934-05-18Hemoglobin [Mass/volume] in Blood8.9g/dL11.6-15 g/dLLowS
1934-05-18Leukocytes [#/volume] in Blood by Automated count1.810*3/uL4-11 10*3/uLLowS
1934-05-18Neutrophils [#/volume] in Blood by Automated count0.410*3/uL1.5-7.5 10*3/uLLowS
1934-05-18Platelets [#/volume] in Blood by Automated count1510*3/uL150-400 10*3/uLLowS
1934-05-18MCV [Entitic mean volume] in Red Blood Cells by Automated count101fL80-100 fLHighS
1934-05-18Reticulocytes [#/volume] in Blood by Automated count1210*3/uL25-100 10*3/uLLowS

Physical Exam

Vital signs recorded on 1934-05-18; see the Vital Signs section. [S]

SystemFinding
GeneralPale, alert, precise, and composed
SkinScattered bruises on the forearms and shins; a few petechiae on the lower legs; thin, scarred fingertip skin
MouthNo gum bleeding or blood blisters; no ulcers
Lymph nodesNo lymphadenopathy
AbdomenNo hepatomegaly or splenomegaly
HeartRegular rhythm, pulse 92; soft flow murmur

Problems

ProblemClinical statusVerificationCodeProvenance
Severe aplastic anemia: pancytopenia with a low reticulocyte count, confirmed by a hypocellular bone marrow; attributed to cumulative occupational ionizing radiation; linked to the documented 1842 diagnosisactiveconfirmed D61.2S — Synthetic modern diagnosis; the 1934 report remains D and the radiation cause is R.
Occupational exposure to ionizing radiation over decades of radium research and X-ray workactiveconfirmed Z57.1S — Synthetic modern coding of the documented exposure history.
Chronic radiodermatitis of the fingertips, with thin, scarred skinactiveconfirmed L58.1S — Synthetic skin finding linked to the documented finger burns.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryCBC with differential and reticulocyte countWeekly during the first months of treatmentCompleted todayBefore treatment: hemoglobin 8.9 g/dL after transfusion, white cells 1.8, neutrophils 0.4, platelets 15, reticulocytes 12 thousand per microliter, MCV 101 fL
LaboratoryBone marrow aspirate and trephine biopsy with cytogeneticsAt diagnosisCompleted todayAbout 10 percent cellularity; no dysplasia, fibrosis, or malignant cells; normal cytogenetics, excluding hypoplastic myelodysplasia
LaboratoryPNH clone by flow cytometryAt diagnosisCompleted todayNo PNH clone
LaboratoryKidney function and potassium before cyclosporineBefore startingUp to dateOne week ago: creatinine 0.78 mg/dL, eGFR 84, potassium 4.1
LaboratoryLiver tests (ALT) before eltrombopagBefore startingDeferredNo ALT is on record before eltrombopag started today; bilirubin was 0.6 mg/dL a week ago. A deviation from the protocol. Corrective action: ALT with the next blood draw
LaboratoryViral serology before immunosuppression (hepatitis B, hepatitis C, HIV, CMV, EBV)At diagnosis, before immunosuppressionDeferredNo results are in this record before treatment started, a deviation from the protocol. Corrective action: flagged to hematology to send with the next blood draw
LaboratoryCyclosporine trough levelRegularly from the first weeks of treatment, to guide the doseDueCyclosporine starts today; first level due within the first weeks
Medication safetyAntiviral prophylaxis during immunosuppressionFrom the start of antithymocyte globulinCompleted todayAcyclovir 400 mg twice daily started
Medication safetyAntibacterial and antifungal prophylaxis while severely neutropenicWhile neutrophils are below 0.5 thousand per microliter, by local policyDeferredNeutrophils 0.4. Not prescribed today; the guideline leaves agent and threshold to local policy. Recorded as a gap for hematology to confirm; same-day fever plan in place
Medication safetyPneumocystis prophylaxisNot routinely required with this regimenNot indicatedNot started
Medication safetyIrradiated, leukocyte-depleted blood productsFrom antithymocyte globulin onwardCompleted todayBlood bank flag placed
ExaminationBlood pressure and weight on cyclosporineEvery visitCompleted today116/70 mmHg, weight 51 kg before cyclosporine
Self-managementSame-day assessment for a temperature of 38 °C or higher; bleeding precautions; no aspirin or NSAIDsEvery visitCompleted todayWritten plan given; thermometer at home
Self-managementNo further occupational radiation exposureWhile counts recoverCompleted todayAway from the laboratory since the first visit
ExaminationComprehensive dilated eye examination with functional vision assessmentEvery 1 to 2 years at 65 or older, and when symptoms limit daily tasksDueRight-eye glare noted; review at the next primary care visit

Goal progress:

Guideline basis: Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline (2024); CMID: Clinical Monitoring Intelligence Database, anemia and cataract monographs (2026)

Follow-up: Antithymocyte globulin course in the hematology unit this week. Weekly blood counts. Primary care review in three weeks with blood counts, kidney function, potassium, ALT, and an eye review. Next scheduled visit 1934-06-08: primary care follow-up three weeks after starting immunosuppressive therapy, with a cataract and eye review. [S]